BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16931400)

  • 1. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells.
    Donmez A; Zoghi M; Cagirgan S; Acarlar C; Tombuloglu M
    Transfus Apher Sci; 2006 Jun; 34(3):245-51. PubMed ID: 16931400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.
    Alessandrino P; Bernasconi P; Caldera D; Colombo A; Bonfichi M; Malcovati L; Klersy C; Martinelli G; Maiocchi M; Pagnucco G; Varettoni M; Perotti C; Bernasconi C
    Bone Marrow Transplant; 1999 Mar; 23(6):533-7. PubMed ID: 10217182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac arrhythmia after infusion of cryopreserved stem cells.
    Keung YK; Lau S; Elkayam U; Chen SC; Douer D
    Bone Marrow Transplant; 1994 Sep; 14(3):363-7. PubMed ID: 7994256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation.
    Martin-Henao GA; Torrico C; Azqueta C; Amill B; Querol S; Garcia J
    Transfusion; 2005 Dec; 45(12):1917-24. PubMed ID: 16371044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
    Hoyt R; Szer J; Grigg A
    Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
    Padley DJ; Dietz AB; Gastineau DA
    Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
    Rodríguez L; Velasco B; García J; Martín-Henao GA
    Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
    Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
    Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
    Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
    Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmia susceptibility in mice after therapy with beta-catenin-transduced hematopoietic progenitor cells after myocardial ischemia/reperfusion.
    Gardiwal A; Reissmann LM; Kotlarz D; Oswald H; Korte T; Landmesser U; Klein G; Templin C
    Cardiology; 2009; 114(3):199-207. PubMed ID: 19602881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.